
News • Tumor identification in CUP patients
Cancer of unknown primary: comprehensive molecular analysis can improve therapy
A considerable proportion of patients suffering from cancer of unknown primary (CUP) could benefit from comprehensive molecular analysis and molecularly-informed targeted therapies.